Table 2 |
|
| Prespecified adverse event preferred terms, MedDRA version 12.1 | |
| Ocular | Nonocular |
| Endophthalmitis | Drug hypersensitivity |
| Panophthalmitis | Hypersensitivity |
| Intraocular pressure, increased | Hypersensitivity NOS (v. 5.1) |
| Ocular hypertension | Anaphylactic shock |
| Glaucoma | Anaphylactic reaction |
| Glaucoma NOS (v. 5.1) | Anaphylactoid shock |
| Glaucoma, traumatic | Anaphylactoid reaction |
| Retinal injury | Angioedema |
| Retinal tear | Angioneurotic edema (v. 5.1) |
| Retinal detachment | Blepharitis, allergic |
| Retinal hemorrhage | Dermatitis, contact |
| Retinal toxicity | Dermatitis, allergic |
| Detachment of retinal pigment epithelium | Toxic skin eruption |
| Retinal pigment epitheliopathy (v. 5.1) | Toxic epidermal necrolysis |
| Eye hemorrhage | Lyell syndrome (v. 5.1) |
| Eye hemorrhage NOS (v. 5.1) | Drug eruption |
| Vitreous hemorrhage | Dermatitis medicamentosa (v. 5.1) |
| Cataract traumatic | Erythema |
| Erythema multiforme | Urticaria |
| Tongue edema | Stevens-Johnson syndrome |
| Pharyngeal edema | Stevens-Johnson syndrome (v. 5.1) |
| Laryngeal edema | Rash |
| Latex allergy | Rash NOS (v. 5.1) |
| Paresthesia oral | Skin reaction |
| Paraesthesia mucosal | Acute generalized exanthematous pustulosis |
| Paraesthesia mucosal NOS (v. 5.1) | Drug rash with eosinophilia and systemic symptoms |
| Antiplatelet Trialists’ Collaboration Events | |
| Cardiovascular | Cerebrovascular |
| Acute myocardial infarction | Brain stem infarction |
| Cardiac arrest | Cerebrovascular accident |
| Cardiac failure congestive | Lacunar infarction |
| Myocardial infarction | Cerebral hemorrhage |
| Retroperitoneal hemorrhage | Transient ischemic attack |
| Sudden death | Peripheral vascular thrombosis |
| Silent myocardial infarction | Pulmonary embolism |
| Coronary artery stenosis | Deep vein thrombosis |
| Acute coronary syndrome | Thrombosis |
| Angina pectoris | Ischemia |
| Angina unstable | Ischemia NOS (v. 5.1) |
MedDRA: Medical Dictionary for Regulatory Activities.
NOS: not otherwise specified.
V: version.
Dombi et al. BMC Ophthalmology 2012 12:37 doi:10.1186/1471-2415-12-37
